The Google owner committed big money to Lyft and Airbnb as GV increased its late-stage deals, formed an AI fund called Gradient and exited from Snap and Cloudera in IPOs.

The University College London gene therapy spinout has completed a series B round backed by the institution's UCL Technology Fund.

The implantable sleep apnoea device developer raised $58.5m in a Zoll Medical-led round that took its total funding past the $140m mark.

Neurological treatment developer Aptinyx has secured $70m in a Nan Fung-backed round to add to the $65m series A it closed in May 2016.

Northwestern University and Osage University Partners both returned to back a $70m series B for Aptinyx, having previously contributed to a $65m series A round in May 2016.

The universities of Sheffield and Leeds have launched a new spinout, Redbrick Molecular, that will market specialty chemicals.

The dental imaging spinout is set to launch technology that gives dental patients a real-time visual impression of ongoing tooth decay.

Diabetes diagnostics developer Zenomics has received $5.8m from biomedical device producer MicroPort Scientific in the first tranche of its first funding round.

Triangle Venture Alliance has made its inaugural investment, backing medical device manufacturer 410 Medical.

UNC-Chapel Hill spinout Falcon Therapeutics has raised a seed round from unnamed backers.